Most-Read Non-COVID-19 News of 2021
Although the pandemic remained a popular healthcare news story in 2021, there were other articles that captured readers’ attention, such as a perspective on the U.S. healthcare system, regulatory changes, and FDA updates.
Americans Show New Interest in Virtual Eye Care Options
Young adults, in particular, are more likely to seek out and place high value on telemedicine for eye care and those in vulnerable populations are benefitting most, according to an annual vision wellness study by VersantHealth.
The U.S. Healthcare System is Broken: A National Perspective
The United States does not have a uniform health system and has no universal healthcare coverage. The health disadvantage of the U.S. relative to other high-income countries is health disparities in health services.
Ready or Not, the New Year Brings Trump’s Price Transparency Rule
The U.S. Circuit Court of Appeals of the District of Columbia ruled that the rule could take effect.
Ophthalmologist Group Wants U.S. Government to Push Back Against Avastin Biosimilars
The American Academy of Ophthalmology says biosimilar alternatives to Avastin have never been tested in the eye.
FDA Update: Merck Action on Keytruda Gastric Cancer Indication Tops Busy Week
Merck will withdraw Keytruda's advanced gastric indication after an FDA panel vote, a drug with supply problems gets a new indication, NDAs for an HIV therapy, and other news.
In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting Loren McCaghy, director of consulting, health and consumer engagement and product insight at Accenture, to discuss the organization's latest report on U.S. consumers switching healthcare providers and insurance payers.
Listen
In our latest "Meet the Board" podcast episode, Managed Healthcare Executive Editors caught up with editorial advisory board member, Eric Hunter, CEO of CareOregon, to discuss a number of topics, one including the merger that never closed with SCAN Health Plan due to local opposition from Oregonians.
Listen
